The new bulletin from the Covid-19 Observatory of the Oswaldo Cruz Foundation (Fiocruz) on the disease in Brazil, released this Friday, 29, pointed out that cases, hospitalizations and deaths are fallingmore alert than pandemic is not over and that there is a need to increase vaccination coverage in some parts of the country, as it is still uneven. The entity highlights the importance of improving booster dose rates, citing the states of Amapá and Roraima, where the population with the third dose is 12%.
In the last two epidemiological weeks, between 10 and 23 April, there was a 36% drop in the number of cases of the disease compared to the period from 27 March to 9 April. Deaths have stabilized at an average of 100 per day, a rate similar to that detected in April 2020, but there was a 43% drop from the previous two weeks.
Fiocruz recommended that states with low rates of immunized population maintain protective measures, such as use of masks indoors e vaccination passport requirement in public transport, workplaces and public buildings. Another guideline is that initiatives to change the status of the pandemic are based on short, medium and long-term action plans.
According to the bulletin, São Paulo is the state that stands out in terms of the percentage of people vaccinated according to the size of the population. 89.8% of the inhabitants are protected with the first dose, 85.2% with the second and 50.6% with the third. Amapá and Roraima are at the opposite extreme, accounting for less than 65% with the first, 50% with the second and 12% with the reinforcement.
“It is still necessary to expand the second dose and invest in age groups that have lower adherence to the application of the vaccine. In addition, it is essential to reinforce the importance and need for the third dose, which cannot be seen only as an extra dose”, informs the document.
The recommendations given by the scientists for the next stages of the pandemic are: strengthening the capacity of field epidemiology teams, introducing surveillance strategies for Acute Respiratory Syndromes (SRG), including Covid-19, and strengthening genomic surveillance for the detection and characterization of new variants.
Continues after advertising
Copyright © Abril Mídia S A. All rights reserved.
Quality and reliable information, just one click away. Subscribe SEE.